Details for New Drug Application (NDA): 214309
✉ Email this page to a colleague
The generic ingredient in MEDROXYPROGESTERONE ACETATE is medroxyprogesterone acetate. There are twenty drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the medroxyprogesterone acetate profile page.
Summary for 214309
Tradename: | MEDROXYPROGESTERONE ACETATE |
Applicant: | Hikma |
Ingredient: | medroxyprogesterone acetate |
Patents: | 0 |
Suppliers and Packaging for NDA: 214309
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MEDROXYPROGESTERONE ACETATE | medroxyprogesterone acetate | INJECTABLE;INJECTION | 214309 | ANDA | Hikma Pharmaceuticals USA inc. | 24201-150 | 24201-150-01 | 1 VIAL in 1 CARTON (24201-150-01) / 1 mL in 1 VIAL (24201-150-00) |
MEDROXYPROGESTERONE ACETATE | medroxyprogesterone acetate | INJECTABLE;INJECTION | 214309 | ANDA | Hikma Pharmaceuticals USA inc. | 24201-150 | 24201-150-25 | 25 VIAL in 1 CARTON (24201-150-25) / 1 mL in 1 VIAL (24201-150-00) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 150MG/ML | ||||
Approval Date: | Jan 5, 2023 | TE: | RLD: | No |
Complete Access Available with Subscription